Last reviewed · How we verify
NCT03637322
Evaluation of Implementation of the Phoenix PrEP (Pre-Exposure Prophylaxis) Access Project for Youth Aged 13-24
trial in Unsafe Sex in 42 participants. Completed in 31 December 2022.
31 December 2022
Quick facts
| Lead sponsor | Phoenix Children's Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 42 |
| Start date | 1 June 2018 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across United States |
Conditions studied
- Unsafe Sex — all drugs for Unsafe Sex →
- IV Drug Usage — all drugs for IV Drug Usage →
Sponsor
Phoenix Children's Hospital
Who can join
Adults 13 to 24, any sex, with Unsafe Sex or IV Drug Usage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the implementation of a PrEP program for youth aged 13-24 in Phoenix, AZ. Numbers of youth who initiate PrEP, how long they continue with PrEP, and the barriers for youth who are trying to initiate and continue taking PrEP will be examined.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03637322
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Phoenix Children's Hospital trials
Trials by the same sponsor.
- NCT06372249 — A Clinical Trial of Soluble Fiber for Asthma · Phase 2 · recruiting
- NCT05925075 — Point of Care Lung Ultrasound in Preterm Infants with Respiratory Distress · enrolling by invitation
- NCT05563610 — Oral Penicillin Challenge and Allergy De-labeling in Children · Phase 4 · terminated
- NCT04344652 — Photoscreening for Retinoblastoma · NA · withdrawn
- NCT04040452 — Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03637322 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Phoenix Children's Hospital
- Last refreshed: 31 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03637322.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing